» Articles » PMID: 25331105

Emerging Technologies to Increase Ligand Binding Assay Sensitivity

Overview
Journal AAPS J
Specialty Pharmacology
Date 2014 Oct 22
PMID 25331105
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Ligand binding assays (LBAs) have been the method of choice for protein analyte measurements for more than four decades. Over the years, LBA methods have improved in sensitivity and achieved larger dynamic ranges by using alternative detection systems and new technologies. As a consequence, the landscape and application of immunoassay platforms has changed dramatically. The introduction of bead-based methods, coupled with single molecule detection standardization and the ability to amplify assay signals, has improved the sensitivity of many immunoassays, in some cases by several logs of magnitude. Three promising immunoassay platforms are described in this article: Single Molecule Counting (SMC™) from Singulex Inc, Single Molecule Arrays (Simoa™) from Quanterix Corporation, and Immuno-PCR (Imperacer®) from Chimera Biotec GmbH. These platforms have the potential to significantly improve immunoassay sensitivity and thereby address the bioanalytical needs and challenges faced during biopharmaceutical drug development.

Citing Articles

Detection and Digital Resolution Counting of Nanoparticles with Optical Resonators and Applications in Biosensing.

Aguirre M, Long K, Li N, Manoto S, Cunningham B Chemosensors (Basel). 2024; 6(2).

PMID: 39559408 PMC: 11573240. DOI: 10.3390/chemosensors6020013.


Immunocapture LC-MS methods for pharmacokinetics of large molecule drugs.

Werth E, Roos D, Philip E Bioanalysis. 2024; 16(7):165-177.

PMID: 38348660 PMC: 11845110. DOI: 10.4155/bio-2023-0261.


Shifting the paradigm in RNA virus detection: integrating nucleic acid testing and immunoassays through single-molecule digital ELISA.

Wang Z, Wei P Front Immunol. 2024; 14:1331981.

PMID: 38235132 PMC: 10791976. DOI: 10.3389/fimmu.2023.1331981.


Non-invasive Biomarkers for Early Detection of Alzheimer's Disease: a New-Age Perspective.

Chimthanawala N, Haria A, Sathaye S Mol Neurobiol. 2023; 61(1):212-223.

PMID: 37596437 DOI: 10.1007/s12035-023-03578-3.


Diagnostic performance of Glial Fibrillary Acidic Protein and Prehospital Stroke Scale for identification of stroke and stroke subtypes in an unselected patient cohort with symptom onset < 4.5 h.

Jaeger H, Tranberg D, Larsen K, Valentin J, Blauenfeldt R, Luger S Scand J Trauma Resusc Emerg Med. 2023; 31(1):1.

PMID: 36604741 PMC: 9814331. DOI: 10.1186/s13049-022-01065-7.


References
1.
Kuo H, Yeh J, Wu P, Jiang C, Wu M . Application of immunomagnetic particles to enzyme-linked immunosorbent assay (ELISA) for improvement of detection sensitivity of HCG. J Immunoassay Immunochem. 2012; 33(4):377-87. DOI: 10.1080/15321819.2012.655820. View

2.
Shukla R, Santoro J, Bender F, Laterza O . Quantitative determination of human interleukin 22 (IL-22) in serum using Singulex-Erenna® technology. J Immunol Methods. 2013; 390(1-2):30-4. DOI: 10.1016/j.jim.2013.01.002. View

3.
Shahim P, Tegner Y, Wilson D, Randall J, Skillback T, Pazooki D . Blood biomarkers for brain injury in concussed professional ice hockey players. JAMA Neurol. 2014; 71(6):684-92. DOI: 10.1001/jamaneurol.2014.367. View

4.
Chang L, Rissin D, Fournier D, Piech T, Patel P, Wilson D . Single molecule enzyme-linked immunosorbent assays: theoretical considerations. J Immunol Methods. 2012; 378(1-2):102-15. PMC: 3327511. DOI: 10.1016/j.jim.2012.02.011. View

5.
Leroux-Roels G, Maes C, Clement F, van Engelenburg F, van den Dobbelsteen M, Adler M . Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes. PLoS One. 2013; 8(2):e55438. PMC: 3577797. DOI: 10.1371/journal.pone.0055438. View